31st week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180214414 | COMPOSITIONS AND METHODS FOR TREATING ESTROGEN-RELATED MEDICAL DISORDERS | 2018-08-02 |
20180214415 | TREATMENT METHOD UTILIZING PYRROLIDINE-2, 5-DIONE DERIVATIVES AS IDO1 INHIBITORS | 2018-08-02 |
20180214416 | TREATMENT FOR WOLFRAM SYNDROME AND OTHER ENDOPLASMIC RETICULUM STRESS DISORDERS | 2018-08-02 |
20180214417 | METHOD FOR TREATING HEPATIC ENCEPHALOPATHY | 2018-08-02 |
20180214418 | MULTISUBSTITUTED AROMATIC COMPOUNDS AS INHIBITORS OF THROMBIN | 2018-08-02 |
20180214419 | COMPOUNDS, COMPOSITIONS, AND METHODS OF INCREASING CFTR ACTIVITY | 2018-08-02 |
20180214420 | Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent | 2018-08-02 |
20180214421 | COMPOSITIONS, METHODS AND KITS FOR REDUCING LIPID LEVELS | 2018-08-02 |
20180214422 | SOLID DISPERSIONS COMPRISING TACROLIMUS | 2018-08-02 |
20180214423 | PHARMACEUTICAL COMPOSITION COMPRISING RAPAMYCIN OR DERIVATIVE THEREOF, AND METHOD FOR PRODUCING THE SAME | 2018-08-02 |
20180214424 | PHARMACEUTICAL COMPOSITIONS COMPRISING 40-O-(2-HYDROXY)ETHYL-RAPAMYCIN | 2018-08-02 |
20180214425 | METHODS OF TREATING BLADDER CANCER | 2018-08-02 |
20180214426 | PYRAZOLO[4,3-C]QUINOLINE DERIVATIVES FOR INHIBITION OF BETA-GLUCURONIDASE | 2018-08-02 |
20180214427 | 3-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-1H-PYRAZOLO[3,4-C]PYRIDINES AND THERAPEUTIC USES THEREOF | 2018-08-02 |
20180214428 | 3-(1H-INDOL-2-YL)-1H-PYRAZOLO[3,4-B]PYRIDINES AND THERAPEUTIC USES THEREOF | 2018-08-02 |
20180214429 | 3-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-1H-PYRAZOLO[4,3-B]PYRIDINES AND THERAPEUTIC USES THEREOF | 2018-08-02 |
20180214430 | Selective Inhibitors Of i-NOS For Use Against Viral Infection | 2018-08-02 |
20180214431 | Methods of Maintaining, Treating or Improving Cognitive Function | 2018-08-02 |
20180214432 | PHARMACEUTICAL COMPOSITION COMPRISING BETAHISTINE | 2018-08-02 |
20180214433 | COMPOSITIONS AND METHODS FOR REDUCING MUSCLE CONTRACTION | 2018-08-02 |
20180214434 | SEMI-SOLID TOPICAL COMPOSITION CONTAINING PIRFENIDONE AND MODIFIED DIALLYL DISULFIDE OXIDE (M-DDO) FOR ELIMINATING OR PREVENTING ACNE | 2018-08-02 |
20180214435 | ORAL PHARMACEUTICAL DOSAGE FORMS | 2018-08-02 |
20180214436 | PHACETOPERANE FOR TREATING OF ATTENTION DEFICIT HYPERACTIVITY DISORDER | 2018-08-02 |
20180214437 | NEW ALFENTANIL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN | 2018-08-02 |
20180214438 | SELECTIVE PFKFB4 INHIBITORS FOR THE TREATMENT OF CANCER | 2018-08-02 |
20180214439 | AZA-CYANOQUINOLINONE PDE9 INHIBITORS | 2018-08-02 |
20180214440 | ORAL COMPOSITION | 2018-08-02 |
20180214441 | Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition | 2018-08-02 |
20180214443 | PHARMACEUTICAL PREPARATION CONTAINING OXYCODONE AND NALOXONE | 2018-08-02 |
20180214444 | Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders | 2018-08-02 |
20180214445 | ARYL SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS | 2018-08-02 |
20180214446 | SOLID STATE FORMS OF SELEXIPAG | 2018-08-02 |
20180214447 | PYRAZOLE PYRIMIDINE DERIVATIVE AND USES THEREOF | 2018-08-02 |
20180214448 | METHOD OF DIAGNOSING AND TREATING SKIN NECROPTOSIS DISEASE COMPRISING RIP3-MLKL PATHWAY BLOCKER | 2018-08-02 |
20180214449 | CANCER THERAPY USING JAK INHIBITOR IN COMBINATION WITH MAPK INHIBITORS | 2018-08-02 |
20180214450 | TREATMENT OF KIDNEY DISEASES ASSOCIATED WITH ELEVATED AVP | 2018-08-02 |
20180214451 | Combination | 2018-08-02 |
20180214452 | COMPOSITION FOR PREVENTION OR TREATMENT OF INTRACTABLE EPILEPSY COMPRISING mTOR INHIBITOR | 2018-08-02 |
20180214453 | RIVAROXABAN PHARMACEUTICAL COMPOSITIONS | 2018-08-02 |
20180214454 | ANTIBIOTIC SOLUTION AND METHOD OF INJECTION TO PREVENT OPHTHALMIC INFECTIONS | 2018-08-02 |
20180214455 | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE | 2018-08-02 |
20180214456 | ORBIT AZINE-FUMARATE, HYDRATE, CRYSTAL FORM AND PREPARATION METHOD THEREFOR | 2018-08-02 |
20180214457 | USE OF CYMANQUINE COMPOUNDS AS ANTIMALARIAL AGENTS | 2018-08-02 |
20180214458 | 1,5-DIHYDRO-2H-PYRROL-2-ONE COMPOUNDS AND METHODS OF USING SAME | 2018-08-02 |
20180214459 | LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS | 2018-08-02 |
20180214460 | TABLET | 2018-08-02 |
20180214461 | PHOSPHOPANTETHEINE COMPOUNDS ALONE OR IN COMBINATION WITH HMG-COA REDUCTASE INHIBITORS FOR LOWERING SERUM CHOLESTEROL AND SERUM TRIGLICERIDES | 2018-08-02 |
20180214462 | BLOOD-BRAIN-BARRIER PERMEABILITY MODULATORS AND USES THEREOF | 2018-08-02 |
20180214463 | USE OF PHYTIC ACID OR THE SALTS THEREOF, ALONE OR COMBINED WITH B6 VITAMERS, FOR PREVENTING THE FORMATION OF ADVANCED GLYCATION END-PRODUCT | 2018-08-02 |
20180214464 | METHODS OF TREATING RETROVIRAL INFECTIONS AND RELATED DOSAGE REGIMES | 2018-08-02 |
20180214465 | THERAPEUTIC USES OF PHARMACEUTICAL COMPOSITIONS COMPRISING CYCLIC BORONIC ACID ESTER DERIVATIVES | 2018-08-02 |
20180214466 | USE OF GINSENOSIDE M1 FOR TREATING IGA NEPHROPATHY | 2018-08-02 |
20180214467 | GLP-1 SECRETAGOGUE | 2018-08-02 |
20180214468 | PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF | 2018-08-02 |
20180214469 | ANTICANCER COMPOSITION AND USE THEREOF | 2018-08-02 |
20180214470 | NEW EFFECTIVE AMINOGLYCOSIDE ANTIBIOTIC FOR MULTIDRUG-RESISTANT BACTERIA | 2018-08-02 |
20180214471 | COMPOSITION FOR PREVENTING AND TREATING OSTEOPOROSIS, COMPRISING DIHYDROPHASEIC ACID 3-O-B-D-GLUCOPYRANOSIDE ISOLATED FROM LYCIUM ROOT BARK EXTRACTS | 2018-08-02 |
20180214472 | CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS | 2018-08-02 |
20180214473 | COMPOSITIONS AND METHODS RELATED TO CHARACTERIZING PROVIRAL RESERVOIRS | 2018-08-02 |
20180214474 | Methods and Compositions for Selecting siRNA of Improved Functionality | 2018-08-02 |
20180214475 | microRNAS FOR THE TREATMENT OF HEART DISEASES | 2018-08-02 |
20180214476 | THROMBIN-RESPONSIVE HYDROGELS AND DEVICES FOR AUTO-ANTICOAGULANT REGULATION | 2018-08-02 |
20180214477 | GRANULAR COMPOSITION FOR ORAL ADMINISTRATION | 2018-08-02 |
20180214478 | POLYMERS FOR REVERSING HEPARIN-BASED ANTICOAGULATION | 2018-08-02 |
20180214479 | MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA | 2018-08-02 |
20180214480 | PHARMACEUTICAL-GRADE FERRIC ORGANIC COMPOUNDS, USES THEREOF AND METHODS OF MAKING SAME | 2018-08-02 |
20180214481 | READY TO USE SURFACE DISINFECTANT | 2018-08-02 |
20180214482 | METHOD OF ENABLING MUSCLE RELAXATION | 2018-08-02 |
20180214483 | THERAPEUTIC METHODS INVOLVING MODULATING INFLAMMASOME ACTIVATION OF MYELOID-DERIVED SUPPRESSOR CELLS | 2018-08-02 |
20180214484 | TUMOR LYSATE LOADED PARTICLES | 2018-08-02 |
20180214485 | TARGETED DISRUPTION OF T CELL RECEPTOR GENES USING ENGINEERED ZINC FINGER PROTEIN NUCLEASES | 2018-08-02 |
20180214486 | BONE MARROW DERIVED CD271 PRECURSOR CELLS FOR CARDIAC REPAIR | 2018-08-02 |
20180214487 | PD-L1 EXPRESSING HEMATOPOIETIC STEM CELLS AND USES | 2018-08-02 |
20180214488 | METHODS AND COMPOSITIONS FOR STEM CELL TRANSPLANTATION | 2018-08-02 |
20180214489 | MESENCHYMAL STEM CELLS WITH ENHANCED EFFICACY IN TREATMENT OF AUTOIMMUNITY PARTICULARLY RHEUMATOID ARTHRITIS | 2018-08-02 |
20180214490 | METHODS OF TREATING LYSOSOMAL STORAGE DISEASES | 2018-08-02 |
20180214491 | COMPOSITIONS AND METHODS FOR EXPANSION OF EMBRYONIC HEMATOPOIETIC STEM CELLS | 2018-08-02 |
20180214492 | Repair of Peripheral Nerve Injury | 2018-08-02 |
20180214493 | Tissue Grafts Composed Of Micronized Placental Tissue And Methods Of Making And Using The Same | 2018-08-02 |
20180214494 | METHOD AND COMPOSITION FOR PREVENTING EGG ALLERGY | 2018-08-02 |
20180214495 | USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS | 2018-08-02 |
20180214496 | COMPOSITIONS COMPRISING BACTERIAL STRAINS | 2018-08-02 |
20180214497 | REPLICATION-COMPETENT VESICULAR STOMATITIS VIRUSES | 2018-08-02 |
20180214498 | METHOD FOR REGULATING, PREVENTING AND/OR TREATING PULMONARY INJURY | 2018-08-02 |
20180214499 | COMPOSITIONS FOR ANTITUSSIVE, EXPECTORANT OR ANTI-INFLAMMATION | 2018-08-02 |
20180214500 | BEAUTYBERRY TOTAL GLYCOSIDES EXTRACT AND PREPARATION METHOD AND USE THEREOF | 2018-08-02 |
20180214501 | Colloidal suspension for the healing of various cancers | 2018-08-02 |
20180214502 | FORMULATIONS FOR WEIGHT LOSS AND METHODS OF USE | 2018-08-02 |
20180214503 | COMPOSITION FOR WOUND TREATMENT CONTAINING EXTRACT OF STELLERA CHAMAEJASME OR FRACTION THEREOF AND METHOD FOR TREATING WOUND OF SUBJECT | 2018-08-02 |
20180214504 | HEALTH SUPPLEMENT FOOD FOR PROMOTION OF HAIR GROWTH, MITIGATION AND ALLEVIATION OF HAIR LOSS, REGULATION OF BLOOD GLUCOSE, AND ALLEVIATION AND RELIEF OF GASTRIC DISORDER SYMPTOMS | 2018-08-02 |
20180214505 | INFLAMMATION-SUPPRESSING COMPOSITION INCLUDING PEPTIDE | 2018-08-02 |
20180214506 | COMBINATION ADMINISTRATION OF GNRH ANTAGONISTS | 2018-08-02 |
20180214507 | COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS | 2018-08-02 |
20180214508 | COMPOSITION CONTAINING CYCLIC DIPEPTIDE AND SWEETENING AGENT | 2018-08-02 |
20180214509 | USE OF A BACTERIUM ISOLATED FROM THE GENUS PSEUDOALTEROMONAS, CYCLOLIPOPEPTIDES AND USES THEREOF | 2018-08-02 |
20180214510 | NON-IRRITANT OPHTHALMIC COMPOSITION CONTAINING CYCLOSPORIN, AND CONVENIENT PREPARATION METHOD | 2018-08-02 |
20180214511 | ENGINEERED ANTHRAX PROTECTIVE ANTIGEN PROTEINS FOR CANCER THERAPY | 2018-08-02 |
20180214512 | ANTI-PATHOGENIC METHODS | 2018-08-02 |
20180214513 | Restoration of Visual Responses by In Vivo Delivery of Rhodopsin Nucleic Acids | 2018-08-02 |
20180214514 | Compositions and Treatments of Metabolic Disorders Using FGF Binding Protein 3 | 2018-08-02 |